イスラエルの化学者が、血液ガン細胞の早期発見に繋がるハイテク技術を開発した
イスラエルの化学者が、血液ガン細胞の早期発見に繋がるハイテク技術を開発した。
これにより、患者への早期治療が可能になる。
New Israeli discovery could help multiple myeloma patients receive earlier and more precise treatment and prevent relapse.
By Naama Barak, ISRAEL21c
Israeli researchers have developed a new technology that profiles the genetic makeup of cancerous cells, allowing for better diagnosis and treatment.
Multiple myeloma is the second most-common type of blood cancer. Multiple myeloma occurs when plasma cells in the bone marrow – the cells that produce antibodies – proliferate out of control and lead to organ failure and death.
A major stumbling block in diagnosing myeloma is that each patient is unique and current blood tests are incapable of identifying early disease onset and classifying which patient should receive which treatment.
